Madrigal Pharmaceuticals (MDGL) Other Accumulated Expenses (2011 - 2016)
Madrigal Pharmaceuticals (MDGL) reported Other Accumulated Expenses of $129,000 for Q2 2016, down 88.7% from $1.14 million a year earlier and down 86.0% from the prior quarter.
Powered by 
Analysis
Madrigal Pharmaceuticals (MDGL) Other Accumulated Expenses (2011 - 2016) Analysis & Trends
At the end of FY2015, Madrigal Pharmaceuticals posted Other Accumulated Expenses of $1.04 million, down 0.3% from FY2014.
- Other Accumulated Expenses has a four-year compound annual growth rate of 14.1% (FY2011 to FY2015).
- By year, Other Accumulated Expenses came in at $1.04 million in FY2014 (+4.4%), $996,000 in FY2013 (+16.4%), $856,000 in FY2012 (+40.1%) and $611,000 in FY2011.
- The Q2 2016 figure ranks as the lowest quarterly Other Accumulated Expenses in data going back to Q4 2011.
- Year over year, Other Accumulated Expenses has now declined in each of the last three quarters, with an average decline of 4.7% over the last eight quarters.
- The high point for year-over-year Other Accumulated Expenses in five years was Q1 2014 (growth of 61.2%); the low point was Q2 2016 (a decline of 88.7%).
- Per Business Quant data, the three quarters before Q2 2016 came in at $921,000 (Q1 2016), $1.04 million (Q4 2015) and $1.1 million (Q3 2015).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Madrigal Pharmaceuticals | 14.56 Bn | 10.81 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2016 | 129,000.00 |
| Mar 31, 2016 | 921,000.00 |
| Dec 31, 2015 | 1.04 Mn |
| Sep 30, 2015 | 1.10 Mn |
| Jun 30, 2015 | 1.14 Mn |
| Mar 31, 2015 | 1.11 Mn |
| Dec 31, 2014 | 1.04 Mn |
| Sep 30, 2014 | 1.06 Mn |
| Jun 30, 2014 | 1.01 Mn |
| Mar 31, 2014 | 982,000.00 |
| Dec 31, 2013 | 996,000.00 |
| Sep 30, 2013 | 793,000.00 |
| Jun 30, 2013 | 781,000.00 |
| Mar 31, 2013 | 609,000.00 |
| Dec 31, 2012 | 856,000.00 |
| Sep 30, 2012 | 813,000.00 |
| Jun 30, 2012 | 718,000.00 |
| Dec 31, 2011 | 611,000.00 |
API Access
Madrigal Pharmaceuticals Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=MDGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "MDGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=MDGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();